JNJ
HealthcareJohnson & Johnson
$224.62-0.93 (-0.41%)PRE
Live · NYSE · May 8, Close
AI Insight
What's Moving JNJ Today?
No stock-specific AI insight has been generated for JNJ yet. Check back soon — insights are generated from recent news analysis.
Fundamentals
Market Cap$540.7B
P/E Ratio—
EPS—
Dividend Yield—
Dividend / Share—
ROE—
Profit Margin—
Debt / Equity—
Trading
Volume8.0M
Avg Volume (10D)—
Shares Outstanding2.41B
JNJ News
72 articles- Zimmer Biomet stock (US98956P1021): Orthopedic device maker reports Q1 results and raises full-year guidanceAD HOC NEWS·May 9, 2026
- The Nationwide Social Security Survey Says Most Americans Are Flying Blind on Benefits, Here’s the Income Strategy That Fills the Gap247 Wall St·May 8, 2026
- Nationwide Survey: 83% of Americans Are Worried Social Security Won’t Survive, and Here’s What to Do About It247 Wall St·May 8, 2026
- Is Bristol Myers Squibb (BMY) Pricing Reflect Recent Pharma Sector Sentiment Shift AccuratelySimply Wall Street·May 8, 2026
- NLPC Rips Colgate-Palmolive at Annual Meeting for Clinging to DEINational Legal and Policy Center·May 8, 2026
- Gene Therapy Briefs: Regeneron Wins FDA Approval for First Neurosensory Gene TherapyGenetic Engineering and Biotechnology News·May 8, 2026
- Gene Therapy Briefs: Regeneron Wins FDA Approval for First Neurosensory Gene TherapyGenetic Engineering and Biotechnology News·May 8, 2026
- AbbVie’s Skyrizi beats out J&J’s Tremfya in in April drug ad spending leaderboardFierce Pharma·May 8, 2026
- Johnson & Johnson launches ‘Generation Fine’ depression projectFierce Pharma·May 8, 2026
- Fierce Pharma Asia—Summit’s surprise interim trial miss; UCB’s $2B Candid buy; J&J’s CAR-T cutsFierce Pharma·May 8, 2026
- 3 Unstoppable Dividend King Stocks to Buy Right Now for Less Than $550Motley Fool·May 8, 2026
- Warren Buffett and Berkshire Hathaway Own 2 Dividend Kings That Will Never Be Sold247 Wall St·May 8, 2026
- Generali Asset Management SPA SGR Sells 32,367 Shares of Merck & Co., Inc. $MRKMarketBeat·May 8, 2026
- Stryker completes acquisition of Amplitude Vascular SystemsMassDevice·May 7, 2026
- DARZALEX royalties drive Genmab’s Q1 revenue higher amid expansion pushYahoo Finance·May 7, 2026
- Johnson And Johnson Balances Mental Health Push With Mixed Pipeline OutlookYahoo Finance·May 7, 2026
- Darzalex, Erleada & New Drugs Keep J&J's Oncology Engine Charged in Q1Yahoo Finance·May 7, 2026
- Why This Income Pro Likes Banks, Chip-Equipment Companies, and MoreYahoo Finance·May 7, 2026
- Johnson & Johnson launches Generation Fine, a New Movement Encouraging Patients to Expect More from Depression Treatment and Aim for RemissionJohnson & Johnson·May 7, 2026
- Johnson & Johnson launches "Generation Fine," a New Movement Encouraging Patients to Expect More from Depression Treatment and Aim for RemissionYahoo Finance·May 7, 2026
- Regeneron Pharmaceuticals, Inc. $REGN Shares Purchased by K.J. Harrison & Partners IncMarketBeat·May 7, 2026
- J&J’s Ottava robot meets goals in gastric bypass studyMedTech Dive·May 7, 2026
- Johnson & Johnson $JNJ Shares Acquired by Truist Financial CorpMarketBeat·May 7, 2026
- Lilly, Gilead lead pharma’s M&A boomPharmavoice·May 7, 2026
- Safer Dividend King to Buy Now: AbbVie or Johnson & Johnson?Motley Fool·May 6, 2026
- J & J Snack Foods Q2 Earnings Call HighlightsMarketbeat·May 6, 2026
- Is Johnson & Johnson Still the Ultimate Safe Dividend Stock to Buy?Motley Fool·May 6, 2026
- 6 Pharma Dividend Stocks Yielding Up to 6.44% — and They’ve Survived Every Market Crash247 Wall St·May 6, 2026
- These 3 Dividend Stocks Have Raised Their Payouts for a Combined 187 Years. Here’s Why That Matters To Passive Income Lovers247 Wall St·May 6, 2026
- Can Pfizer Stock Outrun A $17B Revenue Void?Trefis·May 6, 2026
- Royalty Pharma reports first quarter 2026 resultsYahoo Finance·May 6, 2026
- Avalo shares spike on skin drug data; BioNTech to cut staffBiopharmadive·May 6, 2026
- CellCentric raises $220M for a ‘transformative’ multiple myeloma medicineBiopharmadive·May 6, 2026
- As American Water Works Hikes Its Dividend, Consider Buying AWK Stock in MayBarchart·May 5, 2026
- Moisturizing Cream Market Size to Hit USD 24.54 Billion by 2035, Driven by Rising Skincare Awareness and Demand for Natural Products | Research by SNS InsiderGlobeNewswire Inc.·May 3, 2026
- Got $1,000? Which of These Beaten-Down Healthcare Stocks Is Worth Buying?The Motley Fool·May 2, 2026
- Wound Cleanser Products Market Size is Projected to be USD 5.17 Billion by 2035; Industry is Propelling Owing to the Growing Technological Investments GloballyGlobeNewswire Inc.·May 1, 2026
- Billionaire Investor Cuts Tylenol Maker Kenvue Stake By 64%Benzinga·Apr 24, 2026
- Mental Health Clinical Trials Research Report 2026: $4.89 Bn Market Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035FGlobeNewswire Inc.·Apr 24, 2026
- Small Cap or Megacap: Which Healthcare Stock Is Right for You?The Motley Fool·Apr 22, 2026
Price Data
Open$225.25
Previous Close$225.55
Day High$226.34
Day Low$222.95
52 Week High—
52 Week Low—
Fundamentals
Market Cap$540.7B
P/E Ratio—
EPS—
Dividend Yield—
Dividend / Share—
ROE—
Profit Margin—
Debt / Equity—
Trading
Volume8.0M
Avg Volume (10D)—
Shares Outstanding2.41B
About Johnson & Johnson
Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: innovative medicine and medtech. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. After restructurings in 2023-24, the drug division focuses on three main therapeutic areas: immunology, oncology, and neurology. Geographically, just over half of total revenue is generated in the United States.
HealthcareDrug Manufacturers - General
Company Details
Security TypeStock
ExchangeNYSE
Currency—
Round Lot—
SICDrug Manufacturers - General
CIK—
Composite FIGI—
Share Class FIGI—